Showing results (581-590 of 652) with videos related to
Sort By:
Pageof 66
The Lancet. Gastroenterology & Hepatology|May 20, 2026
Intestinal ultrasound to detect postoperative recurrence in patients with Crohn's disease: an international, multidisciplinary, RAND/UCLA appropriateness method studyChristopher Ma, Siwar Albashir, Mariangela Allocca, et al.Nature Reviews. Gastroenterology & Hepatology|April 22, 2025
Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health responseVirginia Solitano, Charles N Bernstein, Iris Dotan, et al.The Lancet. Gastroenterology & Hepatology|June 12, 2025
Development and validation of a novel Endoscopic ulcer Activity Score for Evaluation of Crohn's Disease (EASE-CD) using data from two randomised controlled trialsChristopher Ma, Reena Khanna, Bryan R Maguire, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 4, 2025
Reliability and Responsiveness of Endoscopic Indices for Assessing Crohn's Disease Postoperative Recurrence in the PREVENT trialJurij Hanzel, Sudheer K Vuyyuru, Brian Bressler, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 3, 2014
The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's diseaseRichard N Fedorak, Brian G Feagan, Naomi Hotte, et al.Journal of Crohn'S & Colitis|October 18, 2022
Application of Deep Learning Models to Improve Ulcerative Colitis Endoscopic Disease Activity Scoring Under Multiple Scoring SystemsMichael F Byrne, Remo Panaccione, James E East, et al.Nature Communications|July 18, 2017
Quantifying the critical thickness of electron hybridization in spintronics materialsT Pincelli, V Lollobrigida, F Borgatti, et al.Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines-Biology, Current Evidence and RecommendationsSanjay K Murthy, M Ellen Kuenzig, Joseph W Windsor, et al.Alimentary Pharmacology & Therapeutics|July 16, 2013
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel diseaseR Khanna, B D Sattin, W Afif, et al.Inflammatory Bowel Diseases|March 14, 2023
Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort StudyMichael J Buie, Stephanie Coward, Abdel-Aziz Shaheen, et al.Pageof 66